ParagonCare Partners with Coreline Soft to Advance AI-Powered Lung Cancer Screening in Australia

ParagonCare has unveiled its strategic partnership with Coreline Soft, an AI-driven, innovative lung cancer screening software designed to enhance early detection and diagnosis.

Coreline Soft’s comprehensive imaging analysis solutions integrate seamlessly into clinical practice and are transforming diagnosis workflows. Their AI-powered medical imaging solutions are revolutionising how hospitals detect and manage multiple conditions from a single CT scan. This creates opportunities for earlier intervention and potentially better patient outcomes.

Coreline Soft’s AVIEW product line offers 3D CT image analysis solutions. AVIEW LCS Plus, which can simultaneously screen for the "BIG 3" in lung cancer screening (lung cancer, emphysema, and coronary artery calcification), supports large-scale data analysis and precise nodule detection. It reduces diagnostic variability among medical professionals and is currently supplied to lung cancer screening programs in South Korea, Europe, Germany, Italy, and more.

“By integrating AI-powered healthcare solutions into our portfolio, ParagonCare is reinforcing its commitment to advancing patient care and streamlining radiology workflows. Our partnership with Coreline Soft is a significant step forward in harnessing innovative technology to support healthcare professionals and improve patient outcomes.” – Tiffany Chiew, General Manager, Capital and Service.

"Partnering with ParagonCare is a significant step in expanding access to our AI lung cancer screening solutions across Australia," said Jason Suh, Director of Overseas Business Department at Coreline Soft. "With their deep expertise in medical imaging and strong local presence, ParagonCare is an ideal partner to bring advanced screening technology to more healthcare providers. Together, we aim to enhance early detection, improve diagnostic accuracy, and support better patient outcomes—starting with the NLCSP in July."

ParagonCare is excited to launch the Coreline Soft to the Australian market at the Australian Lung Cancer Conference (ALCC) 2025, held in Adelaide from 19th to 21st February, South Australia.

This year, with the commencement of the National Lung Cancer Screening Program (NLCSP) in Australia, the conference emphasizes the transformative potential of early detection in reducing lung cancer mortality. ParagonCare is proud to partner with Coreline Soft to support this national initiative by providing solutions that align with evolving screening guidelines and clinical practices.